China Universal Asset Management Company’s Neumora Therapeutics NMRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$23.8K	Buy	32,486 +80	+0.2%	+$59	﹤0.01%	448
2025 Q1	$32.4K	Sell	32,406 -1,851	-5%	-$1.85K	﹤0.01%	442
2024 Q4	$363K	Buy	+34,257	New	+$363K	0.03%	279